Conclusion
VT ablation in patients with CKD results in increased incidence of
adverse clinical events such as greater in-hospital mortality and acute
kidney injury, in addition to increased length of stay and higher
hospital charges. CKD IV and III had higher hospital mortality and
30-day readmission rate, respectively compared with other CKD stages.
Understanding risk of VT ablation in patients with different stages of
CKD will inform discussions of risks and benefits of of patients with
CKD being considered for catheter ablation of VT.